Midodrine Biogaran (Midodrine Hydrochloride)

Midodrine Hydrochloride, the active ingredient in Midodrine Biogaran, is a alpha‑1 adrenergic agonist presented as a tablet for oral use. It is indicated for the management of orthostatic hypotension, helping to raise standing blood pressure and reduce dizziness, light‑headedness, and fainting episodes in adult patients.

GNH USA supplies Midodrine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation, ensuring reliable access to this prescription‑only vasopressor for healthcare providers across global markets.

Midodrine Biogaran is employed in the treatment of disorders characterized by inadequate vascular tone, primarily orthostatic hypotension, by stimulating alpha‑1 adrenergic receptors to increase peripheral resistance and raise blood pressure upon standing.

- Orthostatic hypotension: Improves standing blood pressure and reduces symptoms such as dizziness, light‑headedness, and fainting.

Midodrine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Supine hypertension: increase in blood pressure while lying down. - Piloerection: goose‑flesh skin reaction. - Pruritus: itching sensation. - Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects: - Severe hypertension: marked elevation of blood pressure requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening. - Anaphylaxis: acute allergic reaction with potential airway compromise.

When prescribing Midodrine, clinicians should observe several safety considerations. - Monitor supine blood pressure: check for hypertension when patient is lying down. - Avoid use in severe cardiac disease: patients with uncontrolled heart failure or ischemic heart disease may be at risk. - Use caution in renal impairment: dose adjustment may be needed in reduced kidney function. - Review concomitant antihypertensive therapy: concurrent drugs may blunt the intended effect or cause excessive pressure changes. - Store at ambient temperature: keep tablets in the original packaging, protect from moisture and direct sunlight.

Midodrine can interact with other medicines, influencing blood pressure control.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): combined use may precipitate hypertensive crisis. - Other vasopressors: additive pressor effect can cause severe hypertension. - Sympathomimetic agents: risk of excessive increase in vascular tone.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance orthostatic hypotension when standing. - Beta‑blockers: can blunt compensatory tachycardia, affecting blood pressure response. - Anticholinergic drugs: may increase risk of urinary retention.